<bill session="115" type="h" number="7324" updated="2019-04-18T16:28:56Z">
  <state datetime="2018-12-17">REFERRED</state>
  <status>
    <introduced datetime="2018-12-17"/>
  </status>
  <introduced datetime="2018-12-17"/>
  <titles>
    <title type="official" as="introduced">To clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers, and for other purposes.</title>
    <title type="short" as="introduced">Preserving Access to Orphan Drugs Act of 2018</title>
    <title type="short" as="introduced">Preserving Access to Orphan Drugs Act of 2018</title>
    <title type="display">Preserving Access to Orphan Drugs Act of 2018</title>
  </titles>
  <sponsor bioguide_id="K000376"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-12-17">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-12-17" state="REFERRED">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-12-17">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-01-02">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSWM" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="Health" code="HSWM02" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Health care coverage and access"/>
    <term name="Prescription drugs"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
